AAAAAA

   
Results: 1-16 |
Results: 16
Antiphospholipid antibodies and the coagulation cascade
Authors: Angles-Cano, E Guillin, MC
Citation: E. Angles-cano et Mc. Guillin, Antiphospholipid antibodies and the coagulation cascade, RHEUM DIS C, 27(3), 2001, pp. 573
Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation
Authors: Martinez, C Rivera, J Loyau, S Corral, J Gonzalez-Conejero, R Lozano, ML Vicente, V Angles-Cano, E
Citation: C. Martinez et al., Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation, THROMB HAEM, 85(4), 2001, pp. 686-693
Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins inrheumatic and vascular diseases
Authors: Dominguez, M Cacoub, P de la Torre, IG Piette, JC Salazar-Paramo, M Godeau, P Angles-Cano, E
Citation: M. Dominguez et al., Autoantibodies to receptor induced neoepitopes of fibrinolytic proteins inrheumatic and vascular diseases, J RHEUMATOL, 28(2), 2001, pp. 302-308
Kringles of the plasminogen-prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site
Authors: Dominguez, M Rojas, G Loyau, S Bazurco, M Sorell, L Angles-Cano, E
Citation: M. Dominguez et al., Kringles of the plasminogen-prothrombin gene family share conformational epitopes with recombinant apolipoprotein (a): specificity of the fibrin-binding site, BBA-PROT ST, 1548(1), 2001, pp. 72-80
Experimental study of fibrin/fibrin-specific molecular interactions using a sphere/plane adhesion model
Authors: Lorthois, S Schmitz, P Angles-Cano, E
Citation: S. Lorthois et al., Experimental study of fibrin/fibrin-specific molecular interactions using a sphere/plane adhesion model, J COLL I SC, 241(1), 2001, pp. 52-62
Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies areindependently associated with decreased graft survival in cardiac transplant recipients
Authors: Warshofsky, MK Dominguez, M Eisenberg, MS Wasserman, HS Sciacca, R Wang, WZ Simon, AD Morse, JH Schwartz, A Angles-Cano, E Rabbani, LE
Citation: Mk. Warshofsky et al., Elevated plasma tissue plasminogen activator and anti-THP-1 antibodies areindependently associated with decreased graft survival in cardiac transplant recipients, AM J CARD, 88(1), 2001, pp. 30-34
Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding - An in vitro study using plasma from children with idiopathic nephrotic syndrome
Authors: Soulat, T Loyau, S Baudouin, V Maisonneuve, L Hurtaud-Roux, MF Schlegel, N Loirat, C Angles-Cano, E
Citation: T. Soulat et al., Effect of individual plasma lipoprotein(a) variations in vivo on its competition with plasminogen for fibrin and cell binding - An in vitro study using plasma from children with idiopathic nephrotic syndrome, ART THROM V, 20(2), 2000, pp. 575-584
Lipoprotein Lp(a) and atherothrombotic disease
Authors: de la Pena-Diaz, A Izaguirre-Avila, R Angles-Cano, E
Citation: A. De La Pena-diaz et al., Lipoprotein Lp(a) and atherothrombotic disease, ARCH MED R, 31(4), 2000, pp. 353-359
Experimental study of fibrin embolization under shear flow
Authors: Lorthois, S Schmitz, P Houi, D Angles-Cano, E
Citation: S. Lorthois et al., Experimental study of fibrin embolization under shear flow, J ADHESION, 72(2), 2000, pp. 229-239
High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms
Authors: Angles-Cano, E
Citation: E. Angles-cano, High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms, CIRCULATION, 102(25), 2000, pp. E184-E184
Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome
Authors: Cugno, M Dominguez, M Cabibbe, M Bisiani, G Galli, M Angles-Cano, E Agostoni, A
Citation: M. Cugno et al., Antibodies to tissue-type plasminogen activator in plasma from patients with primary antiphospholipid syndrome, BR J HAEM, 108(4), 2000, pp. 871-875
Plasminogen activation and fibrinolysis in the antiphospholipid syndrome
Authors: Angles-Cano, E
Citation: E. Angles-cano, Plasminogen activation and fibrinolysis in the antiphospholipid syndrome, HUGHES SYNDROME: ANTIPHOSPHOLIPID SYNDROME, 2000, pp. 325-336
Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin - A study with individual plasmas presenting natural variations of Lp(a)
Authors: Soulat, T Loyau, S Baudouin, V Durlach, V Gillery, P Garnotel, R Loirat, C Angles-Cano, E
Citation: T. Soulat et al., Evidence that modifications of Lp(a) in vivo inhibit plasmin formation on fibrin - A study with individual plasmas presenting natural variations of Lp(a), THROMB HAEM, 82(1), 1999, pp. 121-127
Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site
Authors: Hervio, L Brunner, C Sorell, L Kang, C Muller, HJ Angles-Cano, E
Citation: L. Hervio et al., Effect of plasminogen activators on human recombinant apolipoprotein(a) having the plasminogen activation cleavage site, BBA-PROT ST, 1434(1), 1999, pp. 124-134
Immobilisation of monocytes to a solid support: A model for the study of ligand-binding interactions and plasminogen activation at the cell surface
Authors: Soulat, T Dominguez, M Martin, I Angles-Cano, E
Citation: T. Soulat et al., Immobilisation of monocytes to a solid support: A model for the study of ligand-binding interactions and plasminogen activation at the cell surface, THROMB RES, 96(6), 1999, pp. 473-480
A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping
Authors: Angles-Cano, E Loyau, S Cardoso-Saldana, G Couderc, R Gillery, P
Citation: E. Angles-cano et al., A novel kringle-4 number-based recombinant apo[a] standard for human apo[a] phenotyping, J LIPID RES, 40(2), 1999, pp. 354-359
Risultati: 1-16 |